153 related articles for article (PubMed ID: 37469197)
1. Gene-level dissection of chromosome 3q locus amplification in squamous cell carcinoma of the lung using the nCounter assay.
Jeon T; Oh UJ; Min J; Kim C
Thorac Cancer; 2023 Sep; 14(26):2635-2641. PubMed ID: 37469197
[TBL] [Abstract][Full Text] [Related]
2. A broad amplification pattern at 3q in squamous cell lung cancer--a fluorescence in situ hybridization study.
Kettunen E; el-Rifai W; Björkqvist AM; Wolff H; Karjalainen A; Anttila S; Mattson K; Husgafvel-Pursiainen K; Knuutila S
Cancer Genet Cytogenet; 2000 Feb; 117(1):66-70. PubMed ID: 10700870
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of PIK3CA and SOX2 in Asian patients with lung squamous cell carcinoma.
Iijima Y; Seike M; Noro R; Ibi T; Takeuchi S; Mikami I; Koizumi K; Usuda J; Gemma A
Int J Oncol; 2015 Feb; 46(2):505-12. PubMed ID: 25384882
[TBL] [Abstract][Full Text] [Related]
4. True 3q chromosomal amplification in squamous cell lung carcinoma by FISH and aCGH molecular analysis: impact on targeted drugs.
Brunelli M; Bria E; Nottegar A; Cingarlini S; Simionato F; Caliò A; Eccher A; Parolini C; Iannucci A; Gilioli E; Pedron S; Massari F; Tortora G; Borze I; Knuutila S; Gobbo S; Santo A; Tondulli L; Calabrò F; Martignoni G; Chilosi M
PLoS One; 2012; 7(12):e49689. PubMed ID: 23236352
[TBL] [Abstract][Full Text] [Related]
5. Clarifying the spectrum of driver oncogene mutations in biomarker-verified squamous carcinoma of lung: lack of EGFR/KRAS and presence of PIK3CA/AKT1 mutations.
Rekhtman N; Paik PK; Arcila ME; Tafe LJ; Oxnard GR; Moreira AL; Travis WD; Zakowski MF; Kris MG; Ladanyi M
Clin Cancer Res; 2012 Feb; 18(4):1167-76. PubMed ID: 22228640
[TBL] [Abstract][Full Text] [Related]
6. The Landscape of Actionable Molecular Alterations in Immunomarker-Defined Large-Cell Carcinoma of the Lung.
Chan AW; Chau SL; Tong JH; Chow C; Kwan JSH; Chung LY; Lung RW; Tong CY; Tin EK; Law PP; Law WT; Ng CSH; Wan IYP; Mok TSK; To KF
J Thorac Oncol; 2019 Jul; 14(7):1213-1222. PubMed ID: 30978501
[TBL] [Abstract][Full Text] [Related]
7. Amplification of the 3q26.3 locus is associated with progression to invasive cancer and is a negative prognostic factor in head and neck squamous cell carcinomas.
Singh B; Stoffel A; Gogineni S; Poluri A; Pfister DG; Shaha AR; Pathak A; Bosl G; Cordon-Cardo C; Shah JP; Rao PH
Am J Pathol; 2002 Aug; 161(2):365-71. PubMed ID: 12163360
[TBL] [Abstract][Full Text] [Related]
8. DNA gains in 3q occur frequently in squamous cell carcinoma of the lung, but not in adenocarcinoma.
Björkqvist AM; Husgafvel-Pursiainen K; Anttila S; Karjalainen A; Tammilehto L; Mattson K; Vainio H; Knuutila S
Genes Chromosomes Cancer; 1998 May; 22(1):79-82. PubMed ID: 9591638
[TBL] [Abstract][Full Text] [Related]
9. A simple specific pattern of chromosomal aberrations at early stages of head and neck squamous cell carcinomas: PIK3CA but not p63 gene as a likely target of 3q26-qter gains.
Redon R; Muller D; Caulee K; Wanherdrick K; Abecassis J; du Manoir S
Cancer Res; 2001 May; 61(10):4122-9. PubMed ID: 11358835
[TBL] [Abstract][Full Text] [Related]
10. Integrative genomic analyses identify BRF2 as a novel lineage-specific oncogene in lung squamous cell carcinoma.
Lockwood WW; Chari R; Coe BP; Thu KL; Garnis C; Malloff CA; Campbell J; Williams AC; Hwang D; Zhu CQ; Buys TP; Yee J; English JC; Macaulay C; Tsao MS; Gazdar AF; Minna JD; Lam S; Lam WL
PLoS Med; 2010 Jul; 7(7):e1000315. PubMed ID: 20668658
[TBL] [Abstract][Full Text] [Related]
11. Claudin-3 Inhibits Lung Squamous Cell Carcinoma Cell Epithelial-mesenchymal Transition and Invasion via Suppression of the Wnt/β-catenin Signaling Pathway.
Che J; Yue D; Zhang B; Zhang H; Huo Y; Gao L; Zhen H; Yang Y; Cao B
Int J Med Sci; 2018; 15(4):339-351. PubMed ID: 29511369
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 3q arm gain linked to immunotherapy response in advanced cutaneous squamous cell carcinoma.
Kacew AJ; Harris EJ; Lorch JH; Haddad RI; Chau NG; Rabinowits G; LeBoeuf NR; Schmults CD; Thakuria M; MacConaill LE; Hanna GJ
Eur J Cancer; 2019 May; 113():1-9. PubMed ID: 30954880
[TBL] [Abstract][Full Text] [Related]
13. Genome-wide association study identifies a novel susceptibility locus at 12q23.1 for lung squamous cell carcinoma in han chinese.
Dong J; Jin G; Wu C; Guo H; Zhou B; Lv J; Lu D; Shi Y; Shu Y; Xu L; Chu M; Wang C; Zhang R; Dai J; Jiang Y; Yu D; Ma H; Zhao X; Yin Z; Yang L; Li Z; Deng Q; Cao S; Qin Z; Gong J; Sun C; Wang J; Wu W; Zhou G; Chen H; Guan P; Chen Y; Liu X; Liu L; Xu P; Han B; Bai C; Zhao Y; Zhang H; Yan Y; Liu J; Amos CI; Chen F; Tan W; Jin L; Wu T; Hu Z; Lin D; Shen H
PLoS Genet; 2013; 9(1):e1003190. PubMed ID: 23341777
[TBL] [Abstract][Full Text] [Related]
14. PIK3CA mutations as prognostic factor in squamous cell lung carcinoma.
McGowan M; Hoven AS; Lund-Iversen M; Solberg S; Helland Å; Hirsch FR; Brustugun OT
Lung Cancer; 2017 Jan; 103():52-57. PubMed ID: 28024696
[TBL] [Abstract][Full Text] [Related]
15. The importance of EGFR mutation testing in squamous cell carcinoma or non-small cell carcinoma favor squamous cell carcinoma diagnosed from small lung biopsies.
Ho HL; Kao HL; Yeh YC; Chou TY
Diagn Pathol; 2019 Jun; 14(1):59. PubMed ID: 31221183
[TBL] [Abstract][Full Text] [Related]
16. Distinct patterns of somatic genome alterations in lung adenocarcinomas and squamous cell carcinomas.
Campbell JD; Alexandrov A; Kim J; Wala J; Berger AH; Pedamallu CS; Shukla SA; Guo G; Brooks AN; Murray BA; Imielinski M; Hu X; Ling S; Akbani R; Rosenberg M; Cibulskis C; Ramachandran A; Collisson EA; Kwiatkowski DJ; Lawrence MS; Weinstein JN; Verhaak RG; Wu CJ; Hammerman PS; Cherniack AD; Getz G; ; Artyomov MN; Schreiber R; Govindan R; Meyerson M
Nat Genet; 2016 Jun; 48(6):607-16. PubMed ID: 27158780
[TBL] [Abstract][Full Text] [Related]
17. Functional analysis of Discoidin domain receptor 2 mutation and expression in squamous cell lung cancer.
Kobayashi-Watanabe N; Sato A; Watanabe T; Abe T; Nakashima C; Sueoka E; Kimura S; Sueoka-Aragane N
Lung Cancer; 2017 Aug; 110():35-41. PubMed ID: 28676216
[TBL] [Abstract][Full Text] [Related]
18. PIK3CA and TFRC located in 3q are new prognostic factors in esophageal squamous cell carcinoma.
Wada S; Noguchi T; Takeno S; Kawahara K
Ann Surg Oncol; 2006 Jul; 13(7):961-6. PubMed ID: 16788758
[TBL] [Abstract][Full Text] [Related]
19. Amplification of the genes BCHE and SLC2A2 in 40% of squamous cell carcinoma of the lung.
Brass N; Rácz A; Heckel D; Remberger K; Sybrecht GW; Meese EU
Cancer Res; 1997 Jun; 57(11):2290-4. PubMed ID: 9187134
[TBL] [Abstract][Full Text] [Related]
20. FGFR1 amplification in lung squamous cell carcinoma: a systematic review with meta-analysis.
Jiang T; Gao G; Fan G; Li M; Zhou C
Lung Cancer; 2015 Jan; 87(1):1-7. PubMed ID: 25433983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
